Sungening Bio

祥根生物

Sungening Bio

Biotech/Healthcare

Xianggen Biopharmaceuticals starts from drugs addressing unmet clinical needs, focusing on drug R&D in metabolic diseases, oncology, and anti-infective areas, aiming to become a globally renowned innovative drug company. With the vision of 'focusing on new drug R&D that solves clinical needs and…

Latest round: Pre Series A (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-12-01